Ligand validation:5FKO

TDC: 5A,6-ANHYDROTETRACYCLINE

TDC is a Ligand Of Interest in 5FKO designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5FKO_TDC_A_1209	66%	20%	0.107	0.91	2.16	1.25	8	5	0	0	100%	1
5FKM_TDC_A_222	92%	14%	0.072	0.961	2.2	1.71	10	10	0	0	100%	1
4D7M_TDC_A_222	88%	12%	0.084	0.961	1.94	2.17	9	10	0	0	100%	1
5FKN_TDC_A_1209	86%	16%	0.081	0.949	2.26	1.44	7	6	0	0	100%	1
2VKV_TDC_A_1206	82%	26%	0.087	0.941	1.48	1.54	4	9	0	0	100%	1
5FKL_TDC_A_222	80%	18%	0.089	0.937	2.16	1.37	8	6	1	0	100%	1
2XPU_TDC_A_1209	79%	19%	0.083	0.927	1.75	1.69	6	7	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.